Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00262028 · ClinicalTrials.gov registry record · Phase 2
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children
A Phase 2 study, sponsored by Novartis Vaccines.
- Completed
- Registry status
- Phase 2
- Development phase
- 910
- Enrollment target
NCT00262028: Completed Phase 2 study, sponsored by Novartis Vaccines.
NCT00262028 is a Phase 2 study that has completed, run by Novartis Vaccines. The registered enrollment target is 910 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (584% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00262028, a Phase 2 study, has completed, sponsored by Novartis Vaccines.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 910 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and immunogenicity of Novartis (formerly Chiron) Meningococcal ACWY Conjugate Vaccine administered to healthy children ages 1 - 10 years
Primary Outcome
Number of subjects (2-10 years of age) achieving with hSBA titers ≥1:4 against Neisseria meningitidis serogroups A,C,W and Y, one month after receiving one dose of either MenACWY-CRM vaccine or MenACWY-PS vaccine.
Interventions
- BIOLOGICAL MenACWY-CRM Vaccine
- BIOLOGICAL MenACWY-PS Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 910 participants |
| Start Date | 2005-04 |
| Est. Completion | 2006-11 |
| Phase | Phase 2 |
What the finished NCT00262028 record still lists
NCT00262028 is an interventional study that assigns participants to a tested intervention. The registered 910 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (584% higher).
The record links to 0 conditions, and to 2 interventions - of which MenACWY-CRM Vaccine is the first listed.
NCT00262028 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00262028 about?
NCT00262028 is a clinical study titled "Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children". The purpose of this study is to evaluate the safety and immunogenicity of Novartis (formerly Chiron) Meningococcal ACWY Conjugate Vaccine administered to healthy children ages 1 - 10 years
What is the current status of trial NCT00262028?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 910 participants. The study started on 2005-04. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00262028?
The interventions under investigation include: MenACWY-CRM Vaccine (BIOLOGICAL), MenACWY-PS Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00262028?
This trial is sponsored by Novartis Vaccines, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00262028's enrollment target sits among peer trials
910 30th of 2000 higher than 1,971 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06216548 · 909 participants · NA
E-PRIME For Children With Medical Complexity
- NCT05658497 · 908 participants
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- NCT06131840 · 914 participants · Phase 1
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- NCT05739955 · 918 participants · NA
Impact of Enhanced Daily Disinfection on Environmental Contamination in Hospital Rooms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia